Analyst Ratings for AnaptysBio (ANAB) [Neutrals]

ANAB Rating Summary

ANAB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ANAB
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $31.83 (+18.4%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 40%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/21/2021 UBS Eliana Merle New Coverage Neutral
(N/A)
29.00
(N/A)
24.55
(26.88)
9.49% Details
3/9/2021 Wedbush David Nierengarten Downgrade Neutral
(Outperform)
19.00
(35.00)
19.51
(26.88)
37.78% Details
Like ANAB Ratings? Also take a look at GSK, PFNX, ARCT, BMY

ANAB Ratings News